NCT07142772View on ClinicalTrials.gov

Quantitative Assessment of the Etiologies of Megalencephaly Associated With a Detectable Tumor Risk

Not yet recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Megalocephaly
Trial Locations (1)

75013

service Génétique clinique Pitié-Salpêtrière / Trousseau, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT07142772 - Quantitative Assessment of the Etiologies of Megalencephaly Associated With a Detectable Tumor Risk | Biotech Hunter | Biotech Hunter